Pod Pearls feature brief exchanges between a moderator and faculty members on important topics of interest to the practicing clinician. Pod Pearls CME-certified audio files can be listened to online or downloaded to an MP3 player. This format brings the clinical insights physicians have come to expect from Medical Crossfire to the busy clinician who needs to stay up-to-date on the implications of current knowledge on patient care.

New Releases

Cardiology

Gastroenterology

	New Releases
	Biologic Agents for Refractory Ulcerative Colitis Moderator: Stephen B. Hanauer, MD Faculty: Edward V. Loftus, MD; Russell D. Cohen, MD Click here to participate
	Effectiveness of Biologics in Response/Remission of Crohn’s Disease Moderator: Stephen B. Hanauer, MD Faculty: Marla C. Dubinsky, MD; Scott Plevy, MD; Click here to participate
	The Metabolic Syndrome: Insights and Applications Moderator: Christie M. Ballantyne, MD Faculty: Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP; Darren K. McGuire, MD, MHSc; Jorge Plutzky, MD Click here to participate
	Residual Cardiometabolic Risk in Patients Treated to Guideline-Defined Goals Moderator: Christie M. Ballantyne, MD Faculty: Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP; Darren K. McGuire, MD, MHSc; Jorge Plutzky, MD Click here to participate
	Managing Cardiometabolic Risk: The Role of Pharmacotherapy in the Treatment of Overweight and Obesity Moderator: Christie M. Ballantyne, MD Faculty: Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP; Darren K. McGuire, MD, MHSc; Jorge Plutzky, MD Click here to participate
	Patient Selection for Biologic Therapy Use in IBD Moderator: Stephen B. Hanauer, MD Faculty: David G. Binion, MD; Remo Panaccione, MD, FRCPC CME credit for this activity has expired Click here to participate
	Benefits and Risks with Biologics and Conventional Treatment for IBD Relative Safety Versus Relative Risk Moderator: Stephen B. Hanauer, MD Faculty: Gary R. Lichtenstein, MD; Scott E. Plevy, MD CME credit for this activity has expired Click here to participate	Back to top ^
	Cardiology
	Tailoring Clinical Strategies for Patients with Cardiometabolic Risk Moderator: Peter Libby, MD, Chairman Faculty: Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP CME credit for this activity has expired Click here to participate
	Managing Cardiometabolic Risk Rimonabant as an Adjunct to Established Clinical Strategies Moderator: Peter Libby, MD, Chairman Faculty: Louis J. Arrone, MD, ACP CME credit for this activity has expired Click here to participate
	Targeting Abdominal Adiposity–Established and Emerging Strategies Moderator: Peter Libby, MD, Chairman Faculty: Jorge Plutzky, MD CME credit for this activity has expired Click here to participate	Back to top ^
	Gastroenterology
	Patient Selection for Biologic Therapy Use in IBD Moderator: Stephen B. Hanauer, MD Faculty: David G. Binion, MD; Remo Panaccione, MD, FRCPC CME credit for this activity has expired Click here to participate
	Benefits and Risks with Biologics and Conventional Treatment for IBD Relative Safety Versus Relative Risk Moderator: Stephen B. Hanauer, MD Faculty: Gary R. Lichtenstein, MD; Scott E. Plevy, MD CME credit for this activity has expired Click here to participate
	Surgical Versus Medical Management of Ulcerative Colitis Moderator: Stephen B. Hanauer, MD Faculty: Asher Kornbluth, MD; Charles A. Sninsky, MD CME credit for this activity has expired Click here to participate
	Biologic Concomitant Versus Biologic Monotherapy in Crohn's Disease Moderator: Stephen B. Hanauer, MD Faculty: Marla C. Dubinsky, MD; Gordon R. Greenberg, MD CME credit for this activity has expired Click here to participate	Back to top ^